Skip to main content

Tweets

Low dose steroids can negatively impact bone health Dr. Janet Pope discusses abstract L01 presented at ACR22. https://t.co/IbwnvCPszh https://t.co/bpswN5plNi
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
The First Head to Head trial in Axial SpA Dr.Gensler discusses abstract L15 presented at #ACR22. L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic AxSpA: A Randomized Phase IIIb Study https://t.co/J0DT1yw0vQ https://t.co/kKhFQKAy6H
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
Practical Guidance for the Clinical Rheumatologist in Unplanned Pregnancies Women of reproductive age comprise an overwhelming majority of patients with rheumatic and musculoskeletal disease. https://t.co/x44GTLRtnT https://t.co/YlLgqeDRgP
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
2022 ACR/EULAR Giant Cell Arteritis Classification Criteria Giant cell arteritis (GCA) has historically been a clinical diagnosis (visual loss, headache, jaw pain, scalp tenderness, etc) supported by labs and histopathology. https://t.co/DN82rXco3N https://t.co/dpIixCFseT
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
73-87% of autoimmune (RA, SLE, UCTD, APL) pts used HCQ during pregnancy. HCQ significantly reduced pre-eclampsia (20% vs 9%), early-onset pre-eclampsia (8% vs 2.5%), 2nd/3rd trimester pregnancy loss (3% vs. 0.6%) https://t.co/CF5ivHeCmY https://t.co/CYqaCCuZJz
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
Fever, FROST, & Pericarditis Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow and ends with an audience question on "Macro-CK. https://t.co/IFxocGkOxJ https://t.co/OzoS248ZRK
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago

Review of the Rheumatic causes of Pericarditis and their management. Causes: SLE, RA, MCTD, Myositis, EGPA, GPA, IgG4-rel Dz, FMF, TRAPS, CAPS, AOSD, JIA, Sarcoidosis, Kawasakis, GCA, Takayasu's https://t.co/MQmkUe4Yey https://t.co/FSfrznoeBe

Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
JAK Inhibitor Potential in Systemic Sclerosis-Associated ILD The occurrence of interstitial lung disease (ILD) in Systemic sclerosis portends serious morbid and mortal outcomes for those affected. https://t.co/LWHKO0gRu4 https://t.co/i2IOLcAgt3
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
New download available-GCA and PMR New Drugs https://t.co/7Y4g6zvTQx. https://t.co/ZfVO0SRVuL
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
CXCL5 Therapy in Lupus? A new study has shown that restoring the balance of a protein in blood may be a promising treatment option for systemic lupus erythematosus, or lupus, an incurable autoimmune disease. https://t.co/B82Xq5FFNJ. https://t.co/ba2nlFuDsI
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
Low dose steroids can negatively impact bone health Dr. Janet Pope discusses abstract L01 presented at ACR22. https://t.co/eBGMza9tWE https://t.co/wACnLTxATu
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
The First Head to Head trial in Axial SpA Dr.Gensler discusses abstract L15 presented at #ACR22. L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic AxSpA: A Randomized Phase IIIb Study https://t.co/RgwKRJwgoS https://t.co/6LxOURICiE
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
×